Powered by: Motilal Oswal

News

Buy Krsnaa Diagnostics Ltd For Target Rs1,050 - JM Financial Institutional Securities Krsnaa Diagnostics’ ex-Covid, ex-Rajasthan revenue CAGR of c.46% over FY21-23 was strong and underscores robust execution capabilities, in our view. The company is in the process of executing the Rajasthan agreement post a favourable ruling from the Rajasthan High Court – and is guiding towards INR 3bn revenue in FY25 from this tender. Despite significant new centre additions, margins have remained resilient in FY23 but change in mix (towards pathology) and implementation of large...
Buy Krsnaa Diagnostics Ltd For Target Rs1,050 - JM Financial Institutional Securities
Buy Krsnaa Diagnostics Ltd For Target Rs1,050 - JM Financial Institutional Securities
Source: JM Financial Institutional Securities Ltd
7/09/2023 3:15:07 PM
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services Impressive track record, robust outlook to sustain re-rating Demand tailwinds to drive better valuation for industry as well * MAXHEALTH is currently trading at 24x FY25E EV/EBITDA, representing a premium to its historical average of 22x. Moreover, it is also trading at a premium to its hospital peers (21x FY25E EV/EBITDA). * However, we expect MAXHEALTH to continue trading at a premium on relative basis, backed by: a) significant land bank availability in high-demand areas of Delhi...
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
2/09/2023 11:16:59 AM
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services Impressive track record, robust outlook to sustain re-rating Demand tailwinds to drive better valuation for industry as well * MAXHEALTH is currently trading at 24x FY25E EV/EBITDA, representing a premium to its historical average of 22x. Moreover, it is also trading at a premium to its hospital peers (21x FY25E EV/EBITDA). * However, we expect MAXHEALTH to continue trading at a premium on relative basis, backed by: a) significant land bank availability in high-demand areas of Delhi ...
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services
Buy Max Healthcare For Target Rs.660 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
31/08/2023 2:59:10 PM
Healthcare Sector Update : Jul `23 Export trends: Sustaining monthly trends By JM Financial Institutional Securities We analysed export data trends for Jul’23 which appears to be subdued across companies except Syngene. Divis’ exports declined -8% YoY (+50% YoY ex-Molnupiravir) during the month but is trending around average monthly sales of CY23. The pricing trend for Divi’s key products are largely stable with the exception of Naproxen and Beta Carotene which were down 9-10% MoM. Laurus reported a decline in sales of -29%YoY (ex-Paxlovid) at USD 11mn. Suven Pharma’s exports decline...
Healthcare Sector Update : Jul `23 Export trends: Sustaining monthly trends By JM Financial Institutional Securities
Healthcare Sector Update : Jul `23 Export trends: Sustaining monthly trends By JM Financial Institutional Securities
Source: JM Financial Institutional Securities Ltd
26/08/2023 11:14:32 AM
India`s MRI systems market to reach $950 mn by 2030  The domestic magnetic resonance imaging (MRI) systems market will continue to grow at a compound annual growth rate of over 13 per cent to reach $950 million by 2030, according to a report on Thursday. Being home to the largest population in the world, India has an alarmingly increasing rise in chronic and lifestyle diseases. With an increasing emphasis on medical diagnosis before treatments and a growing demand for advanced imaging tools, the need for MRI systems has emerged as an i...
India`s MRI systems market to reach $950 mn by 2030
India`s MRI systems market to reach $950 mn by 2030
Source: IANS
24/08/2023 4:54:26 PM
Healthcare Sector Update : IPM Pulse Acute drags By JM Financial Institutional Securities Ltd The IPM growth improved sequentially to 6.4%YoY in Jul’23 (vs. 5.1% MoM); nonetheless, remains tepid due to delayed seasonality. IPM grew 10.5%YoY based on MAT Jul’23 driven by 4.8% price, 2.9% volume and 2.7% NI growth. We expect growth to pick up in Aug’23. While monthly volumes are yet to sustain positive momentum, we believe FY24 could deliver 2-4% volume growth. Acute therapies with 4%YoY growth lagged chronic therapies by 6%. All top therapies except AI and Respiratory...
Healthcare Sector Update : IPM Pulse Acute drags By JM Financial Institutional Securities Ltd
Healthcare Sector Update : IPM Pulse Acute drags By JM Financial Institutional Securities Ltd
Source: JM Financial Institutional Securities Ltd
24/08/2023 3:16:16 PM
Apollo Hospitals Q1 net down to Rs.214 crore Healthcare major Apollo Hospitals Enterprise Ltd on Friday said it closed the first quarter with a lower net profit of Rs.214.1 crore. In a regulatory filing, Apollo Enterprises said during the quarter ended June 30, 2023, it had earned an operational revenue of Rs.1,688.4 crore (Q1FY23 Rs.1,529.7 crore) and a net profit of Rs.214.1 crore (Rs.333.1 crore). During the quarter under review, the company’s total expenses went up to Rs.1,424.7 crore -- contributed mainly by other ...
Apollo Hospitals Q1 net down to Rs.214 crore
Apollo Hospitals Q1 net down to Rs.214 crore
Source: IANS
11/08/2023 3:54:52 PM
India's MedPlus Health reports 18% rise in Q1 profit on retail demand India's MedPlus Health Services reported a 18.3% rise in first-quarter profit on Monday as increased presence of the pharmacy helped drive its retail sales. The company's consolidated net profit rose to 37.9 million rupees ($458,277.41) in the three months ended June 30, from 32 million rupees, a year earlier. MedPlus Health was benefited from the increased accessibility of its pharmacies through online channels and retail stores in the country. Its revenue rose 29.2% to 12.8...
India's MedPlus Health reports 18% rise in Q1 profit on retail demand
India's MedPlus Health reports 18% rise in Q1 profit on retail demand
Source: Reuters
7/08/2023 8:00:35 PM
Trivitron Healthcare Unveils India's First Fully Automatic Radiation Protection Gloves Manufacturing Facility at AMTZ, Visakhapatnam Trivitron Healthcare, a renowned global medical technology company, proudly unveiled its advanced Radiation Protection Gloves Manufacturing Facility at the Andhra Pradesh MedTech Zone (AMTZ) in Visakhapatnam. This state-of-the-art facility, equipped with cutting-edge technology and advanced automation, reaffirms Trivitron's dedication to delivering top-notch products in radiation protection. It also marks a significant milestone in the healthcare industry as India's first fully automa...
Trivitron Healthcare Unveils India's First Fully Automatic Radiation Protection Gloves Manufacturing Facility at AMTZ, Visakhapatnam
Trivitron Healthcare Unveils India's First Fully Automatic Radiation Protection Gloves Manufacturing Facility at AMTZ, Visakhapatnam
Source: PR Agency
17/07/2023 5:46:30 PM
Aster DM Healthcare rises as its arm acquires remaining 20% stake in Premium Healthcare Aster DM Healthcare is currently trading at Rs. 302.35, up by 0.30 points or 0.10% from its previous closing of Rs. 302.05 on the BSE. The scrip opened at Rs. 302.25 and has touched a high and low of Rs. 307.35 and Rs. 301.45 respectively. So far 7247 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 336.40 on 04-Jul-2023 and a 52 week low of Rs. 193.80 on 14-Jul-2022. Last one week high and low of the scrip stoo...
Aster DM Healthcare rises as its arm acquires remaining 20% stake in Premium Healthcare
Aster DM Healthcare rises as its arm acquires remaining 20% stake in Premium Healthcare
Source: Accord Fintech
14/07/2023 10:45:51 AM
Healthcare Sector Update : FY23 Review A year of base reset, Revlimid, RM inflation By JM Financial Our Pharma coverage for 1Q24e, in line with their past few quarterly trends, is expected to report a healthy Revenue/EBITDA (ex-BIOS) growth of 14%/24%YoY and EBITDA margin of ~24%. US sales, aided by new launches (primarily gRevlimid), drug shortages and stable pricing, along with healthy India performance will continue to drive growth and profitability. NTCPH, DRRD, SUNP and ZYDUSLIF are likely to increase/ sustain their gRevlimid contribution QoQ, largely driving sales over a low base. DRR...
Healthcare Sector Update : FY23 Review A year of base reset, Revlimid, RM inflation By JM Financial
Healthcare Sector Update : FY23 Review A year of base reset, Revlimid, RM inflation By JM Financial
Source: JM Financial Institutional Securities Ltd
12/07/2023 3:19:45 PM
Healthcare Sector Update : Lucknow Hospital Visits Strong potential for healthcare services By Motilal Oswal * We visited the Lucknow facility of Medanta, Lucknow Health City hospital and Apollo Medics (AM) to understand healthcare dynamics of the city and nearby regions. * Despite recording an 8% CAGR in net state domestic product (NSDP) per capita over FY12-22, Uttar Pradesh (UP) lacks high-quality healthcare infrastructure, leading to underserved healthcare demand. Currently, western UP has better healthcare infrastructure and connectivity to metro cities like Delhi and Noida, while significan...
Healthcare Sector Update : Lucknow Hospital Visits Strong potential for healthcare services By Motilal Oswal
Healthcare Sector Update : Lucknow Hospital Visits Strong potential for healthcare services By Motilal Oswal
Source: Motilal Oswal Financial Services Ltd
6/07/2023 12:27:25 PM
Healthcare Sector Update : FY23 Review: A year of base reset, gRevlimid, RM inflation By JM Financial FY23 Review: A year of base reset, gRevlimid, RM inflation In FY23, our Pharma coverage has delivered Revenue/EBITDA growth of 12%/14%YoY driven by key US launches, healthy India business and easing inflationary pressures. gRevlimid launch benefitted players like DRRD, CIPLA, ZYDUSLIF, NTCPH and SUNP and this is expected to increase in FY24. Ex-Revlimid, US base business remained flat with stable price erosion and we expect it to grow in high single digits in FY24 considering key launches ...
Healthcare Sector Update : FY23 Review: A year of base reset, gRevlimid, RM inflation By JM Financial
Healthcare Sector Update : FY23 Review: A year of base reset, gRevlimid, RM inflation By JM Financial
Source: JM Financial Institutional Securities Ltd
29/06/2023 11:40:13 AM
Procter & Gamble India to invest $244 million to set up manufacturing facility Procter & Gamble India said it would invest 20 billion rupees ($243.79 million) to set up a personal healthcare manufacturing facility in the western state of Gujarat. The company will manufacture digestive products that are part of parent P&G's global healthcare product portfolio at the facility, it said in a statement on Wednesday. The facility will be operational in the next few years and become a global export hub for P&G, the Whisper sanitary napkin maker said. T...
Procter & Gamble India to invest $244 million to set up manufacturing facility
Procter & Gamble India to invest $244 million to set up manufacturing facility
Source: Reuters
29/06/2023 11:36:09 AM
Fortis Healthcare gains on partnering with emergency response network RED.Health Fortis Healthcare is currently trading at Rs. 303.65, up by 0.75 points or 0.25% from its previous closing of Rs. 302.90 on the BSE. The scrip opened at Rs. 304.85 and has touched a high and low of Rs. 309.70 and Rs. 303.30 respectively. So far 38174 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 324.80 on 19-Sep-2022 and a 52 week low of Rs. 228.65 on 29-Jun-2022. Last one week high and low of the scrip stood...
Fortis Healthcare gains on partnering with emergency response network RED.Health
Fortis Healthcare gains on partnering with emergency response network RED.Health
Source: Accord Fintech
27/06/2023 5:06:14 PM
MedPlus Health Services inches up on the BSE Medplus Health Services is currently trading at Rs. 810.00, up by 2.00 points or 0.25% from its previous closing of Rs. 808.00 on the BSE. The scrip opened at Rs. 815.00 and has touched a high and low of Rs. 818.15 and Rs. 810.00 respectively. So far 620 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 864.65 on 29-May-2023 and a 52 week low of Rs. 570.00 on 10-Nov-2022. Last one week high and low of the scrip st...
MedPlus Health Services inches up on the BSE
MedPlus Health Services inches up on the BSE
Source: Accord Fintech
22/06/2023 10:03:40 AM
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities Medanta’s 4Q earnings surprised positively driven by better EBITDA margins and higher other income coupled with lower tax rate. Medanta has delivered Revenue/EBITDA/PAT CAGR of 36%/79%/237% respectively over FY21-23. We see new hospitals contribute 33% to revenues in FY23 (vs. 10% in FY19). The new hospitals have ramped-up exceptionally well lending a strong support to overall earnings growth which we expect to sustain. They continue to optically lower the overall ARPOB and occupancy le...
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities
Buy Global Health Limited For Target Rs. 665 - JM Financial Institutional Securities
Source: JM Financial Institutional Securities
20/06/2023 3:52:21 PM
India`s Apollo Hospitals to sell stake in healthcare platform India's Apollo Hospitals Enterprise Ltd plans to raise about $200 million by selling a stake of up to 6% in its online platform, Chief Financial Officer Krishnan Akhileswaran said on Friday. Apollo Hospitals is expecting a valuation of $2.5 billion to $3 billion for the healthcare services platform, Apollo HealthCo Ltd. In May, Apollo's fourth-quarter revenue from healthcare services climbed 18.5% and accounted for 51% of its total revenue.
India`s Apollo Hospitals to sell stake in healthcare platform
India`s Apollo Hospitals to sell stake in healthcare platform
Source: Reuters
3/06/2023 9:07:12 AM
Digital Health Revolution: Transforming Healthcare Delivery External Inbox PHDCCI, today at its headquarters conducted a conference titled, “Digital Health Revolution: Transforming Healthcare Delivery.”   Speaking at the event, Shri S. Gopalakrishnan (IAS), CEO, National Health Authority, Govt. of India, deliberated on importance of Ayushman Bharat Digital Mission (ABDM) and ABHA ID in harnessing the power of technology in Healthcare while enabling an overall seamless and comprehensive Healthcare system. Speaking further, he added...
Digital Health Revolution: Transforming Healthcare Delivery External Inbox
Digital Health Revolution: Transforming Healthcare Delivery External Inbox
Source: PR Agency
31/05/2023 12:59:25 PM
India`s Apollo Hospitals reports rise in Q4 profit before tax on lower costs  Indian healthcare services provider Apollo Hospitals Enterprise Ltd reported a 7.6% rise in its fourth-quarter profit on Tuesday, helped by a fall in input costs. Consolidated profit before tax rose to 2.54 billion rupees ($30.7 million) for the three months ended March 31, from 2.36 billion rupees a year earlier, the company said in a stock exchange filing. Revenue from operations for one of the country's largest hospital chains rose nearly 21% to 43.02 billion rupees, while ...
India`s Apollo Hospitals reports rise in Q4 profit before tax on lower costs
India`s Apollo Hospitals reports rise in Q4 profit before tax on lower costs
Source: Reuters
30/05/2023 5:08:19 PM
Investors in UAE hospital chain Aster eye $300 million India stake sale Investors in Aster DM Healthcare are in talks to sell a 30% stake in the company's India business for about $300 million, two sources with direct knowledge said, the latest potential deal in India's booming healthcare sector. UAE-based and Mumbai-listed Aster runs 32 hospitals, 127 clinics and 521 pharmacies in India and the United Arab Emirates. The current talks are related to the India business and come just as Aster tries to demerge its Gulf business and sell a majority stake i...
Investors in UAE hospital chain Aster eye $300 million India stake sale
Investors in UAE hospital chain Aster eye $300 million India stake sale
Source: Reuters
26/05/2023 3:47:21 PM
Fortis Healthcare trades in green on the BSE Fortis Healthcare is currently trading at Rs. 288.30, up by 0.20 points or 0.07% from its previous closing of Rs. 288.10 on the BSE. The scrip opened at Rs. 288.80 and has touched a high and low of Rs. 290.00 and Rs. 285.35 respectively. So far 12705 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 324.80 on 19-Sep-2022 and a 52 week low of Rs. 219.80 on 20-Jun-2022. Last one week high and low of the scrip stood...
Fortis Healthcare trades in green on the BSE
Fortis Healthcare trades in green on the BSE
Source: Accord Fintech
25/05/2023 11:13:21 AM
Fortis Healthcare gains on reporting 59% rise in Q4 consolidated net profit Fortis Healthcare is currently trading at Rs. 293.55, up by 4.50 points or 1.56% from its previous closing of Rs. 289.05 on the BSE. The scrip opened at Rs. 291.05 and has touched a high and low of Rs. 294.95 and Rs. 286.30 respectively. So far 80436 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 324.80 on 19-Sep-2022 and a 52 week low of Rs. 219.80 on 20-Jun-2022. Last one week high and low of the scrip stood...
Fortis Healthcare gains on reporting 59% rise in Q4 consolidated net profit
Fortis Healthcare gains on reporting 59% rise in Q4 consolidated net profit
Source: Accord Fintech
24/05/2023 12:07:52 PM
Hold Laurus Labs Ltd For Target Rs. 300 - ICICI Direct About the stock: Laurus Labs operates in the segment of generic APIs & FDFs (formulations), custom synthesis and biotechnology. Major focus in APIs is on ARV, oncology and other APIs. • It owns 11 manufacturing units (six FDA approved sites) with 74 DMFs, 32 ANDAs filed (15 Para IV, 11 first to file) and 192 patents granted. • Laurus acquired Richore Life Sciences to diversify in recombinant animal origin free products, enzymes as well as building biologics custom synthesi...
Hold Laurus Labs Ltd For Target Rs. 300 - ICICI Direct
Hold Laurus Labs Ltd For Target Rs. 300 - ICICI Direct
Source: ICICI Direct
22/05/2023 2:33:28 PM
Buy Max Healthcared For Target Rs. 600 - Motilal Oswal Financial Services * Max Healthcare (MAXHEALTH) delivered a marginally better-than-expected operational performance in 4QFY23, aided by a steady improvement in average realization per operating bed (ARPOB) and an increased number of patients treated. Growth prospects remain robust on the back of price hikes, optimization of payor mix/case mix, and bed additions. Further, surplus cash provides scope for inorganic growth opportunities. * We raise our earnings estimates by 6.5%/6% for FY24/FY25, factoring in 1)...
Buy Max Healthcared For Target Rs. 600 - Motilal Oswal Financial Services
Buy Max Healthcared For Target Rs. 600 - Motilal Oswal Financial Services
Source: Motilal Oswal Financial Services Ltd
18/05/2023 2:54:06 PM
WHO advises against non-sugar sweeteners like stevia for weight control Non-sugar sweeteners like stevia should not be taken for weight control or to reduce the risk of noncommunicable diseases (NCDs) like diabetes, according to a new guideline released by the World Health Organisation (WHO) on Monday. Non-sugar sweeteners (NSS) are low- or no-calorie alternatives to free sugars that are generally marketed as aiding weight loss or maintenance of healthy weight, and are frequently recommended as a means of controlling blood glucose in individuals with diabetes....
WHO advises against non-sugar sweeteners like stevia for weight control
WHO advises against non-sugar sweeteners like stevia for weight control
Source: IANS
15/05/2023 5:20:06 PM
Jupiter Life Line Hospitals files IPO papers with SEBI Jupiter Life Line Hospitals has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise funds through an initial public offering (IPO). The IPO comprises fresh issue of equity shares worth Rs 615 crore and an offer for sale (OFS) of 44.5 lakh equity shares by promoter group entities and other shareholders. Proceeds of the fresh issue to the tune of Rs 464 crore will be utilized to retire debt. Besides, funds will be used fo...
Jupiter Life Line Hospitals files IPO papers with SEBI
Jupiter Life Line Hospitals files IPO papers with SEBI
Source: Accord Fintech
12/05/2023 4:42:01 PM
Sanofi India shines on getting nod to demerge consumer healthcare business into separate entity Sanofi India is currently trading at Rs. 6117.00, up by 418.40 points or 7.34% from its previous closing of Rs. 5698.60 on the BSE. The scrip opened at Rs. 5770.00 and has touched a high and low of Rs. 6160.00 and Rs. 5754.25 respectively. So far 9102 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 7020.00 on 01-Jun-2022 and a 52 week low of Rs. 5240.00 on 08-Feb-2023. Last one week high and low of the scrip st...
Sanofi India shines on getting nod to demerge consumer healthcare business into separate entity
Sanofi India shines on getting nod to demerge consumer healthcare business into separate entity
Source: Accord Fintech
11/05/2023 12:53:28 PM
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand India's Procter & Gamble Hygiene and Health Care Ltd reported a dip in quarterly sales on Wednesday, as a pandemic-driven demand for healthcare products waned with new COVID cases dropping across the country. The company said sale of its products, ranging from Vicks inhaler to Whisper sanitary napkin, fell about 1% to 8.81 billion rupees ($107.73 million) in the January-March quarter. Sales surge in the comparable quarter a year earlier was Omicron-driven, the company said in an...
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand
India's P&G Hygiene and Health Care posts drop in Q3 sales on muted demand
Source: Reuters
11/05/2023 9:14:33 AM
Hold Laurus Labs Ltd For Target Rs.300 - ICICI Direct Slowdown in custom synthesis weighs on numbers… About the stock: Laurus Labs operates in the segment of generic APIs & FDFs (formulations), custom synthesis and biotechnology. Major focus in APIs is on ARV, oncology and other APIs. * It owns 11 manufacturing units (six FDA approved sites) with 74 DMFs, 32 ANDAs filed (15 Para IV, 11 first to file) and 192 patents granted. * Laurus acquired Richore Life Sciences to diversify in recombinant animal origin free products, enzym...
Hold Laurus Labs Ltd For Target Rs.300 - ICICI Direct
Hold Laurus Labs Ltd For Target Rs.300 - ICICI Direct
Source: ICICI Direct
9/05/2023 2:39:44 PM
While most global equity markets are rising 5-20% in 2023, India is flat The Nifty, after a weak run in the last four months, bounced back in April with 4.1 per cent MoM gain, Motilal Oswal Financial Services said in a report. Notably, the index was extremely volatile and swung around 776 points before closing 705 points higher. Nifty50 has been underperforming the emerging markets and the world indices in CY23YTD amid varied global macro headwinds viz., inflation, interest rates, and currency, the report said. While most of the global equity markets are ris...
While most global equity markets are rising 5-20% in 2023, India is flat
While most global equity markets are rising 5-20% in 2023, India is flat
Source: IANS
3/05/2023 11:35:24 AM
Medical devices policy aims to make India one of top 5 global suppliers: AiMeD The National Medical Devices Policy, 2023 will fulfill Prime Minister Narendra Modi's and India's aspirations to be self-reliant with regard to medical devices, said a top official of Association of Indian Medical Device Industry (AiMeD). The Union Cabinet on Wednesday approved the National Medical Devices Policy, 2023. "We congratulate the Government wholeheartedly for approving the much-needed, long awaited direction we had sought since the initial draft policy of June 20...
Medical devices policy aims to make India one of top 5 global suppliers: AiMeD
Medical devices policy aims to make India one of top 5 global suppliers: AiMeD
Source: IANS
27/04/2023 1:40:43 PM
Initiative like `One Herb, One Standard` paves way for expansion of Ayush systems  The Ayush Skill Conclave, aimed at promoting skill development in the traditional healthcare sector, was organised by the healthcare sector skill council (HSSC) at the India Habitat Centre here. The HSSC Sub Council on Ayush is working under close ambit of the ministry of Ayush. The Sub Council is actively developing and promoting skill development initiatives in the Ayush sector with the support of Apex bodies, Ayush Industry, Academic Institutions, and other stakeholders. The Co...
Initiative like `One Herb, One Standard` paves way for expansion of Ayush systems
Initiative like `One Herb, One Standard` paves way for expansion of Ayush systems
Source: IANS
25/04/2023 3:05:34 PM
Horizon Healthcare Services Selects Cognizant to Support its Government Healthcare Programs for 1.2 Million Members Cognizant has been selected by Horizon Healthcare Services, Inc. (Horizon), New Jersey's oldest and largest health insurer, to support its government healthcare programs. As part of a 7-year renewal agreement, Cognizant will manage Horizon's claims processing, encounters submissions to the state, provider configuration, and enrollment services for its 1.2 million Medicaid and Dual Eligible Special Needs Plan (D-SNP) members. Cognizant will leverage its TriZetto healt...
Horizon Healthcare Services Selects Cognizant to Support its Government Healthcare Programs for 1.2 Million Members
Horizon Healthcare Services Selects Cognizant to Support its Government Healthcare Programs for 1.2 Million Members
Source: PR Agency
21/04/2023 1:48:41 PM
India`s private equity, venture capital investments surpass $60 bn in 2022 India's private equity and venture capital (PE-VC) investments surpassed $60 billion in 2022 for the third consecutive year amid global headwinds, a report showed on Wednesday. The country's share of PE-VC investments in Asia-Pacific grew from 15 per cent to 20 per cent from 2021 to 2022, as China tailwinds and India's macro robustness made it a bright spot for investing, amidst decelerating capital flow in the region, according to Bain & Company's "India Private E...
India`s private equity, venture capital investments surpass $60 bn in 2022
India`s private equity, venture capital investments surpass $60 bn in 2022
Source: IANS
20/04/2023 2:17:32 PM
Healthcare Sector Update : IPM Pulse AI Respiratory drive growth in March By JM Financial Institutional Securities The IPM growth in Mar’23 was at 19%YoY (4Q at ~16%) driven by higher AI sales and low base effect. 3Y CAGR remains healthy at 13%YoY (~11% for 4Q). Volume growth for MAT Mar’23 is flat YoY and we expect it to be positive hereon. Acute therapies with 22%YoY growth outperformed chronic therapies by 7%. All the top therapies reported positive growth primarily led by AI (+50%) and Respiratory (+49%) followed by Oncology (+24%) and Pain (+22%). Top performers in the listed universe wer...
Healthcare Sector Update : IPM Pulse AI Respiratory drive growth in March By JM Financial Institutional Securities
Healthcare Sector Update : IPM Pulse AI Respiratory drive growth in March By JM Financial Institutional Securities
Source: JM Financial Institutional Securities
17/04/2023 12:54:45 PM
Innovative Health-Tech firm CureBay appoints Vasant Nangia as President to strengthen its leadership team National: CureBay, an innovative health-tech platform focused on bringing high-quality and affordable healthcare to underserved patients in rural India, has announced the appointment of Vasant Nangia as President effective 3 April. In his new role, Nangia will forefront CureBay’s operations and spearhead its efforts to augment its reach and impact across the region. With Vasant’s appointment, CureBay now aims to rapidly scale up from its current 30 e-clinics and pharm...
Innovative Health-Tech firm CureBay appoints Vasant Nangia as President to strengthen its leadership team
Innovative Health-Tech firm CureBay appoints Vasant Nangia as President to strengthen its leadership team
Source: PR Agency
3/04/2023 4:05:51 PM
Funding into Indian healthtech platforms plunges 55% in 2022 Total funding into healthtech companies in India plunged 55 per cent (year-on-year) to $1.4 billion last year, a report showed on Wednesday. The drop is majorly due to a massive decline in late-stage investments from $2.4 billion in 2021 to $606 million in 2022, a drop of 75 per cent, according to data from Tracxn, a global SaaS-based market intelligence platform. Seed-stage funding also fell 52 per cent YoY to $75.2 million in 2022. However, early-stage funding rose 26 per cent to $...
Funding into Indian healthtech platforms plunges 55% in 2022
Funding into Indian healthtech platforms plunges 55% in 2022
Source: IANS
29/03/2023 5:23:04 PM
Digital lending platform LoanTap acquires Unofin Digital lending platform LoanTap on Wednesday said it has acquired Unofin, a healthcare-focused fintech startup, for an undisclosed sum. With this acquisition, LoanTap aims to leverage Unofin's expertise in healthcare financing to expand its reach in the rapidly-growing healthcare sector in the country. Unofin has serviced over 12,000 customers with Rs 120 crore of gross loan disbursals so far. It has partnership with 1,600 healthcare service providers in seven cities, making it ...
Digital lending platform LoanTap acquires Unofin
Digital lending platform LoanTap acquires Unofin
Source: IANS
29/03/2023 9:30:21 AM
Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine  Indian Immunologicals Limited (IIL), a leading vaccine manufacturer has announced receipt of approval from Drugs Controller General of India and State Drug Control Administration for manufacturing of Measles-Rubella (MR) Vaccine. This is the outcome of Indo-Vietnam partnership, where in IIL partnered with Center for Research and Production of Vaccines and Biologicals, also called Polyvac, Vietnam. Measles causes severe, sometimes permanent, complications including pneumonia...
Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine
Indian Immunologicals Limited receives regulatory approval for Measles-Rubella (MR) Vaccine
Source: PR Agency
28/03/2023 12:28:56 PM
AI platforms for healthcare industry to reach $4.3 bn in 2024 The market for Artificial Intelligence (AI) platforms for the entire healthcare industry is set to grow to $4.3 billion in 2024 from $1.5 billion in 2019, according to a report on Monday. This is owing to the added integration of digital health tools and technologies such as AI and Machine Learning (ML) into the healthcare industry due to the impact of the Covid-19 pandemic, said the report by GlobalData, a data and analytics company. Various healthcare companies are already implementin...
AI platforms for healthcare industry to reach $4.3 bn in 2024
AI platforms for healthcare industry to reach $4.3 bn in 2024
Source: IANS
21/03/2023 9:07:29 AM
Indians firms demand Cloud providers to operate together across environments: Oracle As Cloud gets mainstream, Indian organisations of all sizes will increasingly demand in coming years that various cloud solution providers operate with one another-be it a multi-cloud or hybrid cloud environment, a top Oracle executive said on Wednesday. Shailender Kumar, Senior Vice President and Regional Managing Director India and NetSuite JAPAC, told IANS that in India's 'Techade,' businesses and workloads are becoming more complex and the way technology is utilised is chan...
Indians firms demand Cloud providers to operate together across environments: Oracle
Indians firms demand Cloud providers to operate together across environments: Oracle
Source: IANS
16/03/2023 2:57:46 PM
65% telecom towers need fiberisation; 12L towers to be deployed to make India 5G-ready  As India ramps up 5G rollout across the country, the Digital Infrastructure Providers Association (DIPA) on Monday said that to meet the growing demand of large bandwidth and ultra-low latency, 65 per cent of the telecom towers need to be fiberised and 12 lakh towers need to be deployed by FY 2023-24. According to T.R. Dua, Director-General, DIPA, to date, 36 per cent of telecom towers are fiberised and nearly 7,50,000 towers are deployed in India. "Despite proactive support ...
65% telecom towers need fiberisation; 12L towers to be deployed to make India 5G-ready
65% telecom towers need fiberisation; 12L towers to be deployed to make India 5G-ready
Source: IANS
13/03/2023 4:46:16 PM
Aster DM Healthcare inches up as its arm incorporates Joint Venture Company in Riyadh Aster DM Healthcare is currently trading at Rs. 231.50, up by 0.35 points or 0.15% from its previous closing of Rs. 231.15 on the BSE. The scrip opened at Rs. 231.15 and has touched a high and low of Rs. 233.45 and Rs. 231.00 respectively. So far 629 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 275.45 on 04-Nov-2022 and a 52 week low of Rs. 162.65 on 12-May-2022. Last one week high and low of the scrip stood...
Aster DM Healthcare inches up as its arm incorporates Joint Venture Company in Riyadh
Aster DM Healthcare inches up as its arm incorporates Joint Venture Company in Riyadh
Source: Accord Fintech
13/03/2023 9:57:29 AM
H3N2 Flu cases rise in UP's Kanpur Nearly 50 patients have been admitted in a day at Hallet Hospital in Kanpur, after they complained of high fever, persistent cough and shortness of breath. The rising number of H3N2 subtype influenza cases Kanpur has raised the concerns of health department officials. There is a long queue of patients not just outside government hospitals, but even private hospitals are also struggling with the same. Cases with flu-like symptoms, including high fever, persistent cough and acute respi...
H3N2 Flu cases rise in UP's Kanpur
H3N2 Flu cases rise in UP's Kanpur
Source: IANS
8/03/2023 4:41:02 PM
For many years after Independence, there was no long term vision in health sector: Prime Minister Prime minister Narendra Modi on Monday claimed that for several decades after Independence, there was a lack of an integrated approach and long term vision in the health sector. "For several decades after Independence, there was a lack of an integrated approach and a long-term vision in health. We have not kept healthcare restricted only to the health ministry, but have emphasised on the whole of the government approach," he said while addressing a webinar on "Health and Med...
For many years after Independence, there was no long term vision in health sector: Prime Minister
For many years after Independence, there was no long term vision in health sector: Prime Minister
Source: IANS
6/03/2023 11:52:14 AM
Narayana Hrudayalaya rises as its arm acquires stake of ENT in Cayman Narayana Hrudayalaya is currently trading at Rs. 789.00, up by 11.45 points or 1.47% from its previous closing of Rs. 777.55 on the BSE. The scrip opened at Rs. 787.05 and has touched a high and low of Rs. 790.90 and Rs. 783.90 respectively. So far 4336 shares were traded on the counter. The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 810.15 on 10-Nov-2022 and a 52 week low of Rs. 589.90 on 27-Jul-2022. Last one week high and low of the scrip st...
Narayana Hrudayalaya rises as its arm acquires stake of ENT in Cayman
Narayana Hrudayalaya rises as its arm acquires stake of ENT in Cayman
Source: Accord Fintech
6/03/2023 11:23:46 AM
H3N2 flu virus on rise, IMA advises against antibiotic use Several patients have reported a rise in flu cases with symptoms including high grade fever and persistent cough, said the Indian Medical Association on Saturday, while cautioning against use of antibiotics. The mounting infections are due to the H3N2 influenza virus, which lasts between five to seven days, the association said in a statement on Twitter, noting that it is seasonal. Recent data from the Indian Council of Medical Research (ICMR) also shows that H3N2 - a sub-type of the in...
H3N2 flu virus on rise, IMA advises against antibiotic use
H3N2 flu virus on rise, IMA advises against antibiotic use
Source: IANS
4/03/2023 3:54:41 PM